Effects of Down-regulation of HDAC6 Expression on Proliferation, Cell Cycling and Migration of Esophageal Squamous Cell Carcinoma Cells and Related Molecular Mechanisms |
Li, Ning
(The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng)
Tie, Xiao-Jing (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) Liu, Pei-Jie (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) Zhang, Yan (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) Ren, Hong-Zheng (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) Gao, Xin (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) Xu, Zhi-Qiao (The Cancer Diagnosis-Treatment Center of The First People's Hospital of Kaifeng) |
1 | Ai J, Wang Y, Dar JA, et al (2009). HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. Mol Endocrinol, 23, 1963-72. DOI ScienceOn |
2 | Baker M (2010). RNA interference: Homing in on delivery. Nature, 464, 1225-8. |
3 | Banerjee HN, Verma M (2009). Epigenetic mechanisms in cancer. Biomark Med, 3, 397-410. DOI ScienceOn |
4 | Barnes PJ, Adcock IM (2009). Glucocorticoid resistance in inflammatory diseases. Ancet, 373, l905-l7. |
5 | Carew JS, Giles FJ, Nawrocki ST (2008). Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett, 269, 7-17. DOI ScienceOn |
6 | Carter CL, Lin C, Liu CY, et al (2010). Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter. Oncogene, 29, 5427-36. DOI ScienceOn |
7 | Chen J, Zhou H, Li Q, et al (2011). Epigenetic modification of RhoE expression in gastric cancer cells. Oncol Rep, 25, 173-80. |
8 | Duong V, Bret C, Altucci L, et al (2008). Specific activity of class II histone deacetylases in human breast cancer cells. Mol Cancer Res, 6, 1908-19. DOI ScienceOn |
9 | Fan LH, Li LX, Wei YC (2006). The Value of Immunocytochemistry in the Cytological Diagnosis of Serous Ef fusion. J Mod Lb Med, 21, 6-8. |
10 | He QX, Zhu QJ, Chen JO, et al (2006). Application of immunocytochemistry to cytological diagnosis in hydrothorax and ascites. J Wenzhou Med College, 36, 466-8. |
11 | Hideshima T, Bradner JE, Wong J, et al (2005). Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci USA, 102, 8567-72. DOI ScienceOn |
12 | Hrzenjak A, Moinfar F, Kremser ML, et al (2005). Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol Cancer Ther, 5, 2203-10. |
13 | Husain M, Harrod KS (2009). Influenza A virus-induced caspase-3 cleaves the histone deacetylase 6 in infected epithelial cells. FEBS Lett, 583, 2517-20. DOI ScienceOn |
14 | Jiang XX, Zhang QL,Wu WL, et al (2009). Synergistic effects of proteasome inhibitor and Histone Deacetylase Inhibitor on apoptosis and aggresome formation in T Lymphoma cells. J Experim Hematol, 17, 1232-6. |
15 | Kakihana M, Ohira T, Chan D, et al (2009). Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. J Thorac Oncol, 4, 1455-65. DOI ScienceOn |
16 | Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 8, S4-66. |
17 | Kawaguchi Y, Kovacs JJ, McLaurin A, et al (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell, 115, 727-38. DOI ScienceOn |
18 | Kuwano H, Watanabe M, Sadanaga N, et al (1993). Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus. Cancer Lett, 72, 141-7. DOI ScienceOn |
19 | Parkin DM (2000). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. |
20 | Rey M, Irondelle M, Waharte F, et al (2010). HDAC6 is required for invadopodia activity and invasion by breast tumor cells. Eur J Cell Biol, 12, 25-30. |
21 | Sakuma T, Uzawa K, Onda T, et al (2006). Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol, 29, 117-24. |
22 | Shen J, Wang WQ (2011). Enhancement of sensitivity of oral squamous carcinoma cells to cytochrome c mediated apoptosis by histone deacetylase inhibitors. J Med Res, 40, 62-6. |
23 | Shen R, Chinnaiyan AM, Ghosh D (2008). Pathway analysis reveals function al convergence of gene expression profiles in breast cancer. BMC Med Genomics, 1, 28. DOI ScienceOn |
24 | Unoki M (2011). Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers. Recent Pat Anticancer Drug Discov, 6, 116-30. DOI ScienceOn |
25 | Westendorf JJ, Zaidi SK, Cascino JE, et al (2002). Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol, 22, 7982-92. DOI ScienceOn |
26 | Yuan Q, Ye YJ, Fan YS (2006). The application of immunocytochemistrymarkers in cytological differential diagnosis of effusi on smear. 1, 50-3. |
27 | Wilson AJ, Byun DS, Popova N, et al (2006). Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem, 281, 13548-58. DOI ScienceOn |
28 | Wu Y, Song SW, Sun J, et al (2010). IIp45 inhibits cell migration through inhibition of HDAC6. J Biol Chem, 285, 3554-60. DOI ScienceOn |
29 | Xu C, Lee SA, Chen X (2011). RNA interference as therapeutics for hepatocellular carcinoma. Recent Pat Anticancer Drug Discov, 6, 105-15. |
30 | Zhang H, Chen SH, Li YM (2004). Epidemiological investigation of esophageal carcinoma. World J Gastroenterol, 10, 1834-5. |
31 | Zhang J, He Y, Wand SK, et al (2012). Expression of E-cadherin in the tumor tissue and serum of patients with esophageal squamous cell carcinoma. J Central South Univ (Medical Science), 3, 228-32. |
32 | Zhang XG, Li Z, Wang JF, et al (2009). Evaluation of risk factors and prevention strategies of esophageal cancer. World Chinese J Digestol, 17, 677-80. |
33 | Zhang ZH, Zhao LL, Guo HQ, et al (2008). Application of thin-layer cytology smears and immunocytochemistry in identifying the cell types of malignant tumors. JOURNAL??? 35, 332-5. |